高级检索
当前位置: 首页 > 详情页

Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 自然指数

机构: [1]Department of Rheumatology and Immunology, State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China [2]Department of Immunology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 [3]Graduate School of Biomedical Sciences, University of Texas, Houston, TX 77030 [4]Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, 581 83 Linköping, Sweden [5]Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, Shanghai 200031, China [6]Life Sciences Institute, Zhejiang University, Hangzhou 310058, China [7]College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea
出处:
ISSN:

摘要:
Signal transduction from the T cell receptor (TCR) is crucial for T cell-mediated immune responses and, when deregulated, also contributes to the development of autoimmunity. How TCR signaling is regulated is incompletely understood. In this study, we demonstrate a ubiquitin-dependent mechanism in which the deubiquitinase Otud7b has a crucial role in facilitating TCR signaling. Upon TCR ligation, Otud7b is rapidly recruited to the tyrosine kinase Zap70, a central mediator of TCR-proximal signaling. Otud7b deficiency attenuates the activation of Zap70 and its downstream pathways and impairs T cell activation and differentiation, rendering mice refractory to T cell-mediated autoimmune and inflammatory responses. Otud7b facilitated Zap70 activation by deubiquitinating Zap70, thus preventing the association of Zap70 with the negative-regulatory phosphatases Sts1 and Sts2. These findings establish Otud7b as a positive regulator of TCR-proximal signaling and T cell activation, highlighting the importance of deubiquitination in regulating Zap70 function. © 2016 Sun et al.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 1 区 医学
小类 | 1 区 免疫学 1 区 医学:研究与实验
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 免疫学 1 区 医学:研究与实验
第一作者:
第一作者机构: [1]Department of Rheumatology and Immunology, State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China [2]Department of Immunology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030
共同第一作者:
通讯作者:
通讯机构: [2]Department of Immunology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 [3]Graduate School of Biomedical Sciences, University of Texas, Houston, TX 77030
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号